Analyzing Mannatech (NASDAQ:MTEX) and Jushi (OTCMKTS:JUSHF)

Jushi (OTCMKTS:JUSHFGet Free Report) and Mannatech (NASDAQ:MTEXGet Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation.

Analyst Ratings

This is a summary of current recommendations for Jushi and Mannatech, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jushi 0 2 0 0 2.00
Mannatech 0 0 0 0 N/A

Volatility and Risk

Jushi has a beta of -0.16, indicating that its stock price is 116% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.

Institutional and Insider Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 13.0% of Mannatech shares are owned by institutional investors. 21.0% of Jushi shares are owned by company insiders. Comparatively, 53.1% of Mannatech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Jushi and Mannatech’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jushi $269.45 million 0.50 -$65.10 million ($0.33) -2.07
Mannatech $131.96 million 0.12 -$2.24 million ($1.20) -6.80

Mannatech has lower revenue, but higher earnings than Jushi. Mannatech is trading at a lower price-to-earnings ratio than Jushi, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Jushi and Mannatech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Jushi -24.16% -320.66% -10.31%
Mannatech -1.70% -19.19% -4.99%

Summary

Mannatech beats Jushi on 6 of the 10 factors compared between the two stocks.

About Jushi

(Get Free Report)

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.